The AstraZeneca jab is being reviewed by British regulators for a potential link between the vaccine and very rare cases of blood clots. Oxford University has paused a vaccine trial on children and teenagers until the UK’s health regulator has made a decision as to whether to continue using the jab in younger adults. The University has said there are “no safety concerns” but would wait until the evidence had been reviewed. The prime minister defended the Oxford vaccine and urged people to continue to take up their jab appointments.

Regulators in both Britain and the EU have said the AstraZeneca vaccine is safe and effective, though some European countries have halted the use of the inoculation in young people. Research has shown that in 18 million people who have received the vaccine there were 30 cases of blood clots resulting in 7 deaths. The rate for this kind of blood clot is one in 2.5 million people.

Experts have said that taking aspirin or the contraceptive pill is more of a risk than taking the vaccine and that all inoculations can have rare side effects. However, some have urged the UK’s health regulator to pause the vaccine in those younger than 50, as this group are most impacted by the rare blood clots.

Read more: AstraZeneca Covid vaccine rollout to under-50s should be HALTED, says adviser – as trial in kids is paused - [ Ссылка ]

From Brexit breaking news to HD movie trailers, The Sun newspaper brings you the latest news videos and explainers from the UK and around the world.

Become a Sun Subscriber and hit the bell to be the first to know

Read The Sun: [ Ссылка ]
Like The Sun on Facebook: [ Ссылка ]
Follow The Sun on Twitter: [ Ссылка ]
Subscribe to The Sun on Snapchat: [ Ссылка ]

свернуть